Exhibit

Living standards in ASEAN countries are rapidly improving. In Indonesia, GDP per capita has doubled in the past 5 years and mid-income population is expected to double to 52 million by 2015. Combined with the 10% average annual GDP growth in recent years, Indonesia represents great opportunities for companies in the pharmaceutical industry. By exhibiting at CPhI South East Asia (CPhI SEA), your company will gain direct access to key decision makers and buyers in the ASEAN pharma market.

Why is CPhI Southeast Asia better than other pharma exhibitions in the ASEAN region?

1. Pharmaceutical industry focus: by targeting the pharma industry exclusively, CPhI Southeast Asia will bring the most relevant visitors to your exhibition stand

2. High-quality visitors: hundreds of key decision makers and buyers in the ASEAN pharma market, who are strongly interested in sourcing pharma ingredients, packaging and machinery and forming long-term partnerships

3. Reputable exhibition organiser: UBM (LSE: UBM) organises more than 300 events in 21 countries, including CPhI Worldwide, the world's leading pharmaceutical ingredients exhibition. Our expertise is a proven guarantee of the quality of our exhibitions